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Effects of repeated extracorporeal shock wave in urinary biochemical markers of rats1
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ABSTRACT
Purpose: To access the effect of repeated extracorporeal shock wave (ESW) on urinary biochemical markers Methods: 20 rats were
assigned for ESW (Direx Tripter X1® - 14 KV) to one of two groups: G1 (n=10) one ESW; G2 (n=10) two ESWs within a 14-day
interval. Within the twenty-four hour period before and after the application of shock waves, the animals were placed in metabolic cages
for 24 hour urine collection. The ph, creatinine, sodium, potassium, chlorides, calcium, magnesium, phosphorus, oxalates, alkaline
phosphatase and citrates were measured. Twenty-four hours after the material was collected for urinary determination, the animals
underwent nephrectomy of the kidney submitted to the ESW applications and were, then, sacrificed. The kidneys were processed for
hispatological examination. Results: Small variations in the biochemical markers were found in both groups, with no significant
differences between the values obtained either prior to or following the ESW applications, except for citrate and alkaline phosphatase.
Citraturia decreased significantly in group 2, following the second ESWL application (24.8 ± 3.0 mg/day after the first ESWL vs. 15.3
± 2.2 mg/day after the second ESWL; p < 0.05). Alkaline phosphatase increased significantly following ESWL in group I (0.57 ± 0.02
vs. 0.79 ± 0.04 µmol/mg creatinine; p < 0.01) and also in group 2 (0.69 ± 0.05 vs. 0.83 ± 0.03 µmol/mg creatinine; p < 0.05).
Glomerular, interstitial and sub-capsular hemorrhage with perivascular edema was found in the animals in both groups studied.
Conclusions: A significant increase in urinary alkaline phosphatase was found in both groups studied, suggesting a proximal tubule
lesion. In the group of rats undergoing more than one ESWL application, a smaller urinary citrate excretion was noticed, which may be
a factor contributing for the formation of new calculi.
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RESUMO
Objetivo: Avaliar os efeitos renais das ondas de choque eletro-hidráulicas (OCEH), utilizando como parâmetros marcadores bioquímicos
urinários. Métodos: Foram utilizados 20 ratos machos, EPM - Wistar, distribuídos aleatoriamente em dois grupos: G1 (n=10) Animais
submetidos a uma sessão de OCEH. G2 (n=10) Animais submetidos a duas sessões de OCEH separadas por um intervalo de 14 dias. Para
coleta da urina os animais foram mantidos em gaiolas metabólicas 24 horas antes e depois da aplicação das OCEH. Foram medidos o pH,
a creatinina, sódio, potássio, cloretos, cálcio, magnésio, fósforo, oxalato, fosfatase alcalina e citrato. Vinte e quatro horas após a coleta da
urina os animais foram submetidos à nefrectomia do rim envolvido no experimento e, em seguida, sacrificados. Os rins foram então
submetidos aos procedimentos de fixação e coloração histológica com hematoxilina e eosina. Resultados: Pequenas variações nos
marcadores bioquímicos foram detectadas nos dois grupos, sem diferenças significantes nos valores obtidos antes e após a aplicação
das OCEH, exceto para os valores urinários de citrato e fosfatase alcalina. A citratúria diminuiu significantemente nos animais do
Grupo 2 após a segunda aplicação das OCEH( 24,8 ± 3,0 mg/dia após a primeira sessão de OCEH e 15,3 ± 2,2 mg/dia após a segunda
sessão de OCEH; p < 0.05). A fosfatase alcalina urinária aumentou de forma significante no grupo 1 após a sessão de OCEH
(0,57 ± 0,02 vs. 0,79 ± 0,04 µmol/mg de creatinina; p < 0,01) e também no grupo 2 (0,69 ± 0,05 vs. 0,83 ± 0,03 µmol/mg de
creatinina; p < 0,05). Os achados histológicos observados nos animais dos dois grupos foram: hemorragia glomerular, intersticial e
subcapsular, acompanhada de edema perivascular. Conclusões: Observou-se um aumento significante da fosfatase alcalina urinária
nos dois grupos estudados, sugerindo uma lesão dos túbulos proximais causada pelas ondas de choque eletro-hidráulicas. Nos animais
submetidos a mais de uma sessão de OCEH observou-se um discreto aumento na excreção urinária de citrato, o que pode ser um fator
que pode contribuir para a formação de novos cálculos.
Descritores: Doenças Urológicas. Litíase. Litotripsia. Marcadores Bioquímicos. Ratos.
1Research performed at the Laboratory of Experimental Surgery, Federal University of Sao Paulo (UNIFESP), Brazil.
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Introduction
The management of urolithiasis is based on the
identification of both the baseline disease that made possible the
formation of calculi and the use of medical substances that either
alter the course of the baseline disease or modify the biochemical
composition of the urine. Once the presence of the stone is found
in the excretory routes, means must be found to eliminate it since,
besides causing symptoms; it can give rise to complications such
as obstruction, repeated infections and partial or total loss of the
renal function. Although in the past twenty-five years there has
been an improvement in the quality of endoscopy devices, enabling
better access to the site where the stone is impacted, extracorporeal
shock wave lithotripsy (ESWL) continues to be the only non-
invasive treatment method1-3.
ESWL is considered an effective procedure, highly
successful in selected patients4-7. Despite its acknowledged
efficacy, short and long term adverse effects have been reported,
such as perirenal and sub-capsular hematoma, and even chronic
alterations such as glomerularsclerosis and focal or segmentary
parenchymatous fibrosis7-13. A transitory loss in the renal function
has been reported in patients with normal renal function, which
returns to normal after four days from the application of the
extracorporeal shock waves; such alterations, however, may last
longer in patients with an already compromised renal function.
Increased rates of recurrence following ESWL have
been reported, and in some studies with a long term follow-up,
approximately 70% of patients presented with at least one new
stone3,4. Fragments of post-ESWL remaining stones, immersed in
supersaturated urine, would serve as nuclei for posterior new stone
formation15,14.
The number and intensity of the shock waves are
potential lesion factors13-16. The consequences of the trauma
imposed by the shock waves have been studied by using markers
such as the urinary enzymes N-acetyl-beta-glucosaminidase,
beta-galactosidase, gama-glutamil-transferase and high molecular
weight proteins (macroglobulins and calbidin D28K). Such enzymes
however can be altered, in a brief and transitory fashion, after a
single or sequential sessions of extracorporeal electromagnetic
shock waves14-22. The presence of multiple renal stones or stones
that fail to respond well to a single application of shock waves
demands, within the short term, an ESWL reapplication. In such
cases, the harmful effects may no longer be brief and they may
alter the function in a consistent manner. Detecting an alteration
in the biochemical composition of the urine may be a manner to
assess the consequences of those alterations20.
This study aimed to observe the possible alterations in
the biochemical composition of the urine of animals undergoing
repeated applications of extracorporeal shock wave lithotripsy.
Methods
The experimental protocol was approved by the Ethics
Committee of Federal University of Sao Paulo and follow the
Council for International Organization of Medical Sciences
(CIOMS) ethical code for animal experimentation (WHO Chrinicle
1985; 39(2):51-6) and the principles of the Brazilian College on
Animal Experimentation (www.cobea.org.br). All surgical
procedures and ESW were done under general anesthesia
(intramuscular via) with ketamine (60 mg.kg-1) and xylasine
(5 mg.kg-1).
Initially 20 male Wistar rats weighing between 250-270g
underwent laparotomy and a radiopaque device (a piece of
radiopaque surgical gauze, 0.2 cm in diameter) was sutured at
the adipose tissue situated in the anterior face of the right renal
pelvis near the renal parenchyma. The standard position of the
X-ray marker was confirmed through the simple posteroanterior
radiographic method.
The animals were randomly assigned to two groups:
Group 1 – (N=10) Animals undergoing one application
of 2,000 electro-hydraulic shock waves of 14Kv intensity.
Group 2 – (N=10) Animals undergoing two applications
of 2.000 electro-hydraulic shock waves of 14Kv intensity, with a
14-day interval.
On day fourteen postoperative, using the same anesthetic
procedures, the animals in both groups were affixed to the
lithotripsy table, underwent the shock waves application through
a Direx Tripter X1® device. The renal marker was located and
focused in the fluoroscopy monitor and the lithotripsy device was
then turned on. Two thousand shock waves of 14KV intensity were
applied, generating a wave displacement in aqueous solution equal
to 540 BAR, within approximately 30 minutes. After 14 days from
the first application, the animals in group 2 underwent the second
application of 2,000 shock waves in the same intensity and same
technique, totaling 4,000 shock waves. Twenty-four hours before
and after the shock waves application, the animals were placed in
metabolic cages for a 24-hour urine collection. The urine collected
was lyophilized for posterior analysis of all samples together. The
ph, creatinine, sodium, potassium, chlorides, calcium, magnesium,
phosphorus, oxalates, alkaline phosphatase and citrates were
determined. pH was measured by using a pH potentiometer (Orion
Research – Model 301), with three consecutive determinations,
using the mean measurements. Creatinine was measured through
the alkaline picrate method and photometric reading (Architect -
Ci 8200 - Abbott) and expressed in milligrams per deciliter (mg/dL).
Sodium, chloride and potassium were measured by the selective
electrode method (Architect - Ci 8200 - Abbott) and expressed
in millimoles per liter (mMol/L). Calcium was measured by the
colorimetric method (Architect - Ci 8200 – Abbott), by using
ortho-cresolphthalein as indicator and expressed in milligrams per
liter (mg/L). Urinary oxalate was measured by the Fraser &
Campbell method, modified and expressed in milligrams per 24 hs
(mg/24 hs), through spectrophotometer reading. Citrate was
measured by modified Calamera’s spectrophotometric reaction
and expressed in milligrams per 24 hs (mg/24 hs). Phosphorus
was measured by the phosphomolybdate colorimetric method
(Architect - Ci 8200 – Abbott) and expressed in milligrams per
liter (mg/L). Magnesium was measured by the colorimetric method
(Architect - Ci 8200 – Abbott) and expressed in milligrams per
liter (mg/L). Uric acid was measured by the uricase UV method
(Architect - Ci 8200 – Abbott) and expressed in milligrams per
liter (mg/L). The alkaline phosphatase enzyme was measured by
kinetic-enzymatic reaction, by using Byosis enzymatic-photometric
kits (Architect - Ci 8200 – Abbott) and expressed in International
Units per liter (UI/L).
Twenty-four hours after the collection of material for
urinary measurement the animals were again anesthetized and
underwent median laparotomy for the right nephrectomy to be
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performed. Euthanasia was performed by aortic section.
Immediately following the nephrectomy, the kidneys were fixed in
a 10% formalin solution, for 24 hours. The specimens were
cleavaged and processed with progressive dehydration in ethyl
alcohol, diafanized in xylol, impregnated by paraffin according
to standard protocols.
Four-micra sections were made, placed in slides
previously smeared with Meyer albumin and kept to dry in stoves
regulated at 37oC temperature for 24 hours. Those sections were
stained by the hematoxylin and eosin technique (HE). Subcapsular,
interstitial and glomerular hemorrhage and perivascular edema were
assessed to show that the shock wave had actually been applied in
the renal parenchyma.
The urinary measurement values obtained were subject to
the Kolmogorov-Smirnov test. As they failed to present normal
distribution, we used the Mann-Whitney-Wilcoxon non-parametric
test to compare the means before and after the ESWL application.
The results were expressed by the mean ± standard deviation.
Standard statistics software (Minitab 11.0, Minitab Inc., USA) was
used. Statistical significance was considered at 5% level (p < 0.05).
Results
The urinary electrolyte values found can be seen in
Table 1. Slight variations were observed in both groups, with no
significant differences between the values obtained prior to and
following the ESW application, except for the citrate. Citraturia
decreased significantly in group 2, after the second ESW application
(24.8 ±  3.0 mg/day after the first ESW vs. 15.3 ±  2.2 mg/day after
the second ESW; p < 0.05)).
Alkaline phosphatase increased significantly following
ESW in group I (0.57 ±  0.02 vs. 0.79 ±  0.04 µmol/mg creatinine;
p < 0.01) as well as in group 2 (0.69 ±  0.05 vs. 0.83 ±  0.03 µmol/mg
creatinine post-ESW; p < 0.05).
TABLE1 - Urinary values in the two groups
*p < 0,05.
**p < 0,01
Urinary Values Group 1 
Before ESW 
Group 1 
After ESW 
Group 2 
Before ESW
Grou 2 
After ESW 
pH 7,73 7,72 7,77 7,79 
Na (mmol/day) 0,8±0,04 0,7±0,02 1,1±0,1 1,0±0,2 
K (mmol/day) 1,5±0,2 1,2±0,4 1,7±0,08 1,6±0,2 
Cl (mmol/day) 1,2±0,5 0,9±0,2 0,9±0,35 1,1±0,2 
P (mg/day) 13±2,1 15±1,3 12±2,2 11,7±1,5 
Mg (mg/day) 1,8±0,7 1,9±1,0 1,4±0,9 1,5±0,7 
Ca (mg/day) 0,8±0,07 0,8±0,09 0,6±0,03 0,7±0,04 
Creat (mg/day) 9,5±0,6 10±0,4 8,5±0,7 9,1±0,7 
Uric Acid 
(mg/day) 
1,17±0,37 1,15±0,28 1,09±0,63 1,07±0,22 
Oxalate 
(mg/day) 
0,3±0,22 0,4±0,03 0,6±0,05 0,5±0,05 
Citrate 
(mg/day) 
22,6±1,4 20,2±3,2 24,8±3,0* 15,3±2,2* 
Alkaline 
Phosphatase 
(µmol/mg creat) 
0,57±0,02** 0,79±0,04** 0,69±0,05* 0,83±0,03* 
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Glomerular, interstitial and sub-capsular hemorrhage, with perivascular edema
was observed in the animals in both groups studied (Figures 1 to 3).
FIGURE 1 - Animal from Group 1 showing sub-capsular (black arrow) and intersticial hemorrhage
(white arrow). H&E. 40X
FIGURE 2 - Animal from Group 2 showing sub-capsular hemorrhage (arrow). H&E. 40X
Discussion
Extracorporeal shock wave
lithotripsy (ESW) has changed the
management of urinary stones, since it
is a non-invasive form of treatment
that can be used in most patients,
regardless of age23. Although ESW is
safe and effective, studies in animal
models and in humans have shown that
tissue lesions may occur, altering the
tubule function and reducing the renal
blood flow24,25. The severity of such
alterations is related, among further
factors, to the number, intensity and
type of shock waves administered26,27.
The ischemia and inflammation that
occur due to the trauma, contribute
towards the appearance of fibrosis and
loss of parenchymatous functional
mass28. Since they are focal lesions
and due to the large renal functional
reserve that usually remains, there is a
small incidence of clinically apparent
dysfunctions.
Determination of urinary
excretion of some enzymes may serve
as a non-invasive and even sensitive test
for the occasional renal lesions. To
that end several enzymes have already
been put to the test. The alanine
aminopeptidase enzyme increases
when there is a major renal lesion,
lactic dehydrogenase and n-acetyl-
glucosaminidase increase in cases of
renal cell or subjacent muscle lesion28-30.
In this study, we used urinary alkaline
phosphatase, an enzyme present on the
surface of the proximal tubule brush
border, as marker of the renal lesions
resulting from the ESW. A significant
increase in its urinary excretion could
be detected in the animals in both
groups, probably due to both the action
of the shock waves and the proximal
tubule repair  and cicatr izat ion
mechanisms. Most likely, also due to
those two reasons, no significant
difference was found in the urinary
excretion of alkaline phosphatase
between both groups of animals. Those
lesions were concomitant to the ones
found in the histological exams.
A further problem that occurs
in patients undergoing ESW is the
increased rate of urinary stone
recurrence following the treatment.
Residual fragments have been found
to be difficult to eliminate, even if
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who had not formed new stones or that presented with no growth
in the pre-existing stones. More recently Sarica et al.37 assessed
the effects of the treatment with potassium citrate in children to
prevent new stones, based on the post-ESW remaining fragments.
The children with residual fragments that received no treatment
with potassium citrate had a significant formation of new stones
after one year follow-up.
Citrate is an important inhibitor of urinary calculosis. It
reduces urinary saturation as it forms complexes with calcium,
inhibits spontaneous nucleation and delays the aggregation of
oxalate crystals in vitro1. It is also a powerful growth inhibitor
of calcium phosphate crystals, preventing the heterogeneous
nucleation of calcium oxalate by monosodium urate crystals38. These
biological properties turn the citrate into a potentially effective
inhibitor of stone formation. The rats undergoing two sessions of
ESW (group 2) were found, in this study, to present significantly
decreased citraturia whereas citrate secretion was not altered in the
urine of the rats undergoing just one application. This reduced
citraturia in the animals undergoing more than one session of
ESW is most likely due to the fact that the citrate is an enzyme
predominantly of the proximal tubules, site where the lesions caused
by the shock waves were mostly felt. Citraturia reductions like the
ones found, even if transitory, may be a predisposing factor for
lithogenesis.
A limitation in this study is the fact that a quite large area
of the renal surface, larger than occurring in the daily clinical
practice, is affected by ESW. It did show, however, that it is
important to continue searching for sensitive markers of the
occasional residual renal lesions that certainly must exist, and
that the determination of the urinary citrate concentration can be
a sensitive marker in the prevention of formation of new calculi
following ESW therapy.
Conclusions
A significant increase in urinary alkaline phosphatase was
found in both groups studied, suggesting a proximal tubule lesion.
In the group of rats undergoing more than one ESW application,
smaller urinary citrate excretion was observed, which can be a
factor contributing towards the formation of new calculi.
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